Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt -β-catenin and Wnt - RhoA - Rac1 pathways

Journal of Cell Biology

Volumn 184, Issue 1, 2009, Pages 83-99

  De Jesus Perez, Vinicio A ^a   Alastalo, Tero Pekka ^b   Wu, Jenny C ^a   Axelrod, Jeffrey D ^a   Cooke, John P ^a   Amieva, Manuel ^b   Rabinovitch, Marlene ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; DISHEVELLED 1; GLYCOGEN SYNTHASE KINASE 3BETA; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD1 PROTEIN; SMAD3 PROTEIN; WNT PROTEIN; BMP2 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; DISHEVELLED PROTEINS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMAD1 PROTEIN, HUMAN; WNT3 PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SCID MOUSE; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETICS; HYPERTENSION; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYPERTENSION; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEINS; PULMONARY ARTERY; RAC1 GTP-BINDING PROTEIN; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; WNT PROTEINS;

EID: 59849099675     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200806049     Document Type: Article

References (82)

1. Adams, R.H., and K. Alitalo. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8:464-478.
2. Asosingh, K., M.A. Aldred, A. Vasanji, J. Drazba, J. Sharp, C. Farver, S.A. Comhair, W. Xu, L. Licina, L. Huang, et al. 2008. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am. J. Pathol. 172:615-627.
3. Attisano, L., and J.L. Wrana. 2002. Signal transduction by the TGF-beta superfamily. Science. 296:1646-1647.
4. Axelrod, J.D., and H. McNeill. 2002. Coupling planar cell polarity signaling to morphogenesis. Scientif cWorldJournal. 2:434-454.
5. Axelrod, J.D., J.R. Miller , J.M. Shulman, R.T. Moon, and N. Perrimon. 1998. Differential recruitment of Dishevelled provides signaling specif city in the planar cell polarity and Wingless signaling pathways. Genes Dev. 12:2610-2622.
6. Bain, G., T. Muller, X. Wang, and J. Papkoff. 2003. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301:84-91.
7. Beppu, H., M. Kawabata, T. Hamamoto, A. Chytil, O. Minowa, T. Noda, and K. Miyazono . 2000 . BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev. Biol. 221:249-258.
8. Boutros, M., N. Paricio, D.I. Strutt, and M. Mlodzik. 1998. Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell. 94:109-118.
9. Capelluto, D.G., T.G. Kutateladze, R. Habas, C.V. Finkielstein, X. He, and M. Overduin . 2002 . The DIX domain targets dishevelled to actin stress f bres and vesicular membranes. Nature. 419:726-729.
10. Chen, C., H. Chen, J. Sun, P. Bringas Jr ., Y. Chen, D. Warburton, and W. Shi. 2005 . Smad1 expression and function during mouse embryonic lung branching morphogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L1033-L1039.
11. Cohen, P., and S. Frame. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2:769-776.
12. Cottin, V., S. Dupuis-Girod, G. Lesca, and J.F. Cordier. 2007. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respiration. 74:361-378.
13. Date, T.,Y. Doiguchi, M. Nobuta, and H. Shindo. 2004. Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro. J. Orthop. Sci. 9:503-508.
14. Deckers, M.M., R.L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van Der Bent, S.E. Papapoulos, and C.W. Lowik. 2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 143:1545-1553.
15. Deng, Z., J.H. Morse, S.L. Slager, N. Cuervo, K.J. Moore, G. Venetos, S. Kalachikov, E. Cayanis, S.G. Fischer, R.J. Barst, et al. 2000. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet. 67:737-744.
16. Ding, Q., W. Xia, J.C. Liu, J.Y. Yang, D.F. Lee, J. Xia, G. Bartholomeusz, Y. Li, Y. Pan, Z. Li, et al. 2005. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol. Cell 19:159-170.
17. Endo,Y.,V.Wolf,K.Muraiso,K.Kamijo,L.Soon,A.Uren,M.Barshishat-Kupper, and J.S. Rubin. 2005. Wnt-3a-dependent cell motility involves RhoA activation and is specif cally regulated by dishevelled-2. J. Biol. Chem. 280:777-786.
18. Fischer, L., G. Boland, and R.S. Tuan. 2002. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J. Cell. Biochem. 84:816-831.
19. Foletta, V.C., M.A. Lim, J. Soosairajah, A.P. Kelly , E.G. Stanley, M. Shannon, W. He, S. Das, J. Massague, and O. Bernard. 2003. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 162:1089-1098.
20. Glinka, A., W. Wu, H. Delius, A.P. Monaghan, C. Blumenstock, and C. Niehrs. 1998 . Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 391:357-362.
21. Habas, R., I.B. Dawid, and X. He. 2003. Coactivation of Rac and Rho by Wnt/ Frizzled signaling is required for vertebrate gastrulation. Genes Dev. 17:295-309.
22. Hansmann, G., R.A. Wagner , S. Schellong, V.A. Perez, T. Urashima, L. Wang, A.Y. Sheikh, R.S. Suen, D.J. Stewart, and M. Rabinovitch. 2007. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 115:1275-1284.
23. He, T.C., A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein, and K.W. Kinzler. 1998. Identif cation of c-MYC as a target of the APC pathway. Science. 281:1509-1512.
24. Hu, M.C., and N.D. Rosenblum. 2005. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development. 132:215-225.
25. Humbert, M., N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, I.M. Lang, B.W. Christman, E.K. Weir, O. Eickelberg, N.F. Voelkel, and M. Rabinovitch . 2004a . Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 43:13S-24S.
26. Humbert, M., O. Sitbon, and G. Simonneau. 2004b. Treatment of pulmonary arterial hypertension. N. Engl. J. Med. 351:1425-1436.
27. Ishikawa, T., Y. Tamai, A.M. Zorn, H. Yoshida, M.F. Seldin, S. Nishikawa, and M.M. Taketo . 2001 . Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development. 128:25-33.
28. Ishitani, T., J. Ninomiya-Tsuji, S. Nagai, M. Nishita, M. Meneghini, N. Barker , M. Waterman, B. Bowerman, H. Clevers, H. Shibuya, and K. Matsumoto. 1999 . The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature. 399:798-802.
29. Ishitani, T., J. Ninomiya-Tsuji, and K. Matsumoto. 2003. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinaserelated Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol. Cell. Biol. 23:1379-1389.
30. Jin , E.J. , S.Y. Lee , Y.A. Choi , J.C. Jung , O.S. Bang , and S.S. Kang. 2006. BMP- 2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Mol. Cells. 22:353-359.
31. Kishida, S., H. Yamamoto, and A. Kikuchi. 2004. Wnt-3a and Dvl induce neurite retraction by activating Rho-associated kinase. Mol. Cell. Biol. 24:4487-4501.
32. Labbe, E., A. Letamendia, and L. Attisano. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specif c factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc. Natl. Acad. Sci. USA. 97:8358-8363.
33. Lamalice, L., F. Le Boeuf, and J. Huot. 2007. Endothelial cell migration during angiogenesis. Circ. Res. 100:782-794.
34. Langenfeld, E.M., and J. Langenfeld. 2004. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol. Cancer Res. 2:141-149.
35. Li, L., H. Yuan, W. Xie, J. Mao, A.M. Caruso, A. McMahon, D.J. Sussman, and D. Wu . 1999 . Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J. Biol. Chem. 274:129-134.
36. Liu, Z., Y. Tang, T. Qiu, X. Cao, and T.L. Clemens. 2006. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J. Biol. Chem. 281:17156-17163.
37. Logan, C.Y., and R. Nusse . 2004 . The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20:781-810.
38. Long, L., M.R. MacLean,T.K. Jeffery,I.Morecroft,X.Yang,N.Rudarakanchana, M. Southwood, V. James, R.C. Trembath, and N.W. Morrell. 2006. Serotonin increases susceptibility to pulmonary hypertension in BMPR2- def cient mice. Circ. Res. 98:818-827.
39. Machado, R.D., M.W. Pauciulo, J.R. Thomson, K.B. Lane, N.V. Morgan, L. Wheeler, J.A. Phillips III, J. Newman, D. Williams, N. Galie, et al. 2001. BMPR2 haploinsuff ciency as the inherited molecular mechanism for primary pulmonary hypertension. Am. J. Hum. Genet. 68:92-102.
40. Machado, R.D., N. Rudarakanchana, C. Atkinson, J.A. Flanagan, R. Harrison, N.W. Morrell, and R.C.Trembath. 2003. Functional interaction betweenBMPR- II and Tctex-1, a light chain of Dynein, is isoform-specif c and disrupted by mutations underlying primary pulmonary hypertension. Hum. Mol. Genet. 12:3277-3286.
41. Masckauchan, T.N., C.J. Shawber, Y. Funahashi, C.M. Li, and J. Kitajewski. 2005 . Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis. 8:43-51.
42. Masri, F.A., W. Xu, S.A. Comhair , K. Asosingh, M. Koo, A. Vasanji, J. Drazba, B. Anand-Apte, and S.C. Erzurum. 2007. Hyperproliferative apoptosisresistant endothelial cells in idiopathic pulmonary arterial hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L548-L554.
43. Massague, J. 2003. Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev. 17:2993-2997.
44. Mishina,Y.,A. Suzuki, N. Ueno, and R.R. Behringer. 1995. Bmpr encodes a type
45. I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9:3027-3037.
46. Miyazono, K., and K. Miyazawa. 2002. Id: a target of BMP signaling. Sci. STKE. doi:10.1126/stke.2002.151.pe40.
47. Moriguchi, T., K. Kawachi, S. Kamakura, N. Masuyama, H. Yamanaka, K. Matsumoto, A. Kikuchi, and E. Nishida. 1999. Distinct domains of mouse dishevelled are responsible for the c-Jun N-terminal kinase/stressactivated protein kinase activation and the axis formation in vertebrates. J. Biol. Chem. 274:30957-30962.
48. Moule, S.K., G.I. Welsh, N.J. Edgell, E.J. Foulstone, C.G. Proud, and R.M. Denton . 1997 . Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272:7713-7719.
49. Nusse, R., and H.E. Varmus. 1992. Wnt genes. Cell. 69:1073-1087.
50. Peifer, M. 1997. Beta-catenin as oncogene: the smoking gun. Science. 275: 1752-1753.
51. Raida, M., J.H. Clement, R.D. Leek, K.Ameri, R. Bicknell, D. Niederwieser, and A.L. Harris. 2005. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J. Cancer Res. Clin. Oncol. 131:741-750.
52. Rawadi, G., B.Vayssiere, F. Dunn, R. Baron, and S. Roman-Roman. 2003. BMP- 2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18:1842-1853.
53. Rich, S., D.R. Dantzker, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, K.M. Detre, A.P. Fishman, R.M. Goldring, B.M. Groves, S.K. Koerner, et al. 1987 . Primary pulmonary hypertension. A national prospective study. Ann. Intern. Med. 107:216-223.
54. Roberts, K.E., J.J. McElroy , W.P. Wong, E. Yen, A. Widlitz, R.J. Barst, J.A. Knowles, and J.H. Morse. 2004. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur. Respir. J. 24:371-374.
55. Sakao, S., L. Taraseviciene-Stewart, K. Wood, C.D. Cool, and N.F. Voelkel. 2006 . Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L362-L368.
56. Sandquist, J.C., K.I. Swenson, K.A. Demali, K. Burridge, and A.R. Means. 2006. Rho kinase differentially regulates phosphorylation of nonmuscle myosin
57. II isoforms A and B during cell rounding and migration. J. Biol. Chem. 281:35873-35883.
58. Seki, K., and A. Hata. 2004. Indian hedgehog gene is a target of the bone morphogenetic protein signaling pathway. J. Biol. Chem. 279:18544-18549.
59. Skovseth, D.K., T. Yamanaka, P. Brandtzaeg, E.C. Butcher, and G. Haraldsen. 2002 . Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodef cient mice. Am. J. Pathol. 160:1629-1637.
60. Skovseth, D.K., A.M. Kuchler, and G. Haraldsen. 2007. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation. Methods Mol. Biol. 360:253-268.
61. Song, Y., J.E. Jones, H. Beppu, J.F. Keaney Jr ., J. Loscalzo, and Y.Y. Zhang. 2005 . Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation. 112:553-562.
62. Sugimori, K., K. Matsui, H. Motomura, T. Tokoro, J. Wang, S. Higa, T. Kimura , and I. Kitajima . 2005 . BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J. Bone Miner. Metab. 23:411-419.
63. Suzuki, K., D. Bachiller, Y.P. Chen, M. Kamikawa, H. Ogi, R. Haraguchi, Y. Ogino, Y. Minami, Y. Mishina, K. Ahn, et al. 2003. Regulation of outgrowth and apoptosis for the terminal appendage: external genitalia development by concerted actions of BMP signaling . Development. 130:6209-6220.
64. Tang, S.J., P.A. Hoodless, Z. Lu, M.L. Breitman, R.R. McInnes, J.L. Wrana, and M. Buchwald. 1998. The Tlx-2 homeobox gene is a downstream target of BMP signalling and is required for mouse mesoderm development. Development. 125:1877-1887.
65. Teichert-Kuliszewska, K., M.J. Kutryk, M.A. Kuliszewski, G. Karoubi, D.W. Courtman, L. Zucco, J. Granton, and D.J. Stewart. 2006. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ. Res. 98:209-217.
66. Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422-426.
67. Thomson, J.R., R.D. Machado, M.W. Pauciulo, N.V. Morgan, M. Humbert, G.C. Elliott, K. Ward, M.Yacoub, G. Mikhail, P. Rogers, et al. 2000. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J. Med. Genet. 37:741-745.
68. Thornton, T.M., G. Pedraza-Alva, B. Deng, C.D. Wood, A. Aronshtam, J.L. Clements, G. Sabio, R.J. Davis, D.E. Matthews, B. Doble, and M. Rincon. 2008. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science. 320:667-670.
69. Torres, M.A., and W.J. Nelson. 2000. Colocalization and redistribution of dishevelled and actin during Wnt-induced mesenchymal morphogenesis. J. Cell Biol. 149:1433-1442.
70. Tuder, R.M., and N.F. Voelkel. 2002. Angiogenesis and pulmonary hypertension: a unique process in a unique disease. Antioxid. Redox Signal. 4 : 833-843 .
71. van Nieuw Amerongen, G.P., and V.W. van Hinsbergh. 2001. Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler. Thromb. Vasc. Biol. 21:300-311.
72. Wang, J., N.S. Hamblet, S. Mark, M.E. Dickinson, B.C. Brinkman, N. Segil, S.E. Fraser , P. Chen , J.B. Wallingford , and A. Wynshaw-Boris . 2006. Dishevelled genes mediate a conserved mammalian PCP pathway to regulate convergent extension during neurulation. Development. 133:1767-1778.
73. Warner, D.R., R.M. Greene, and M.M. Pisano. 2005. Interaction between Smad 3 and Dishevelled in murine embryonic craniofacial mesenchymal cells. Orthod. Craniofac. Res. 8:123-130.
74. Wright, M., M. Aikawa, W. Szeto, and J. Papkoff. 1999. Identif cation of a Wntresponsive signal transduction pathway in primary endothelial cells. Biochem. Biophys. Res. Commun. 263:384-388.
75. Yamaguchi, K., K. Shirakabe, H. Shibuya,K.Irie, I. Oishi, N. Ueno, T.Taniguchi, E. Nishida, and K. Matsumoto. 1995. Identif cation of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science. 270:2008-2011.
76. Yang, N., O. Higuchi, K. Ohashi, K. Nagata, A. Wada, K. Kangawa, E. Nishida, and K. Mizuno. 1998. Cof lin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature. 393:809-812.
77. Yang, X., L. Long, M. Southwood, N. Rudarakanchana, P.D. Upton, T.K. Jeffery , C. Atkinson , H. Chen , R.C. Trembath , and N.W. Morrell. 2005. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ. Res. 96:1053-1063.
78. Yeager , M.E., G.R. Halley , H.A. Golpon, N.F. Voelkel, and R.M. Tuder. 2001. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ. Res. 88:E2-E11.
79. Yu,A., J.F. Rual, K.Tamai,Y.Harada, M.Vidal, X. He, andT. Kirchhausen. 2007. Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity signaling. Dev. Cell. 12:129-141.
80. Yu, P.B., H. Beppu, N. Kawai, E. Li, and K.D. Bloch. 2005. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specif c gain of signaling in pulmonary artery smooth muscle cells. J. Biol. Chem. 280:24443-24450.
81. Zhang, T.,T. Otevrel, Z. Gao, Z. Gao, S.M. Ehrlich, J.Z. Fields, and B.M. Boman. 2001a. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61:8664-8667.
82. Zhang, X., J.P. Gaspard, and D.C. Chung. 2001b . Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 61:6050-6054.